Paolo Lanzetta

13.0k total citations
211 papers, 4.4k citations indexed

About

Paolo Lanzetta is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Paolo Lanzetta has authored 211 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Ophthalmology, 121 papers in Radiology, Nuclear Medicine and Imaging and 20 papers in Molecular Biology. Recurrent topics in Paolo Lanzetta's work include Retinal Diseases and Treatments (142 papers), Retinal Imaging and Analysis (82 papers) and Retinal and Optic Conditions (74 papers). Paolo Lanzetta is often cited by papers focused on Retinal Diseases and Treatments (142 papers), Retinal Imaging and Analysis (82 papers) and Retinal and Optic Conditions (74 papers). Paolo Lanzetta collaborates with scholars based in Italy, United States and France. Paolo Lanzetta's co-authors include Daniele Veritti, Valentina Sarao, Francesco Bandello, Anat Loewenstein, Gianni Virgili, Ugo Menchini, Sebastián Wolf, Ursula Schmidt‐Erfurth, Frank G. Holz and Francesca Menchini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Paolo Lanzetta

197 papers receiving 4.2k citations

Peers

Paolo Lanzetta
Winfried M. K. Amoaku United Kingdom
Armin Wolf Germany
Andrew A. Moshfeghi United States
David J. Browning United States
Lyndell L. Lim Australia
J.F. Vander United States
Winfried M. K. Amoaku United Kingdom
Paolo Lanzetta
Citations per year, relative to Paolo Lanzetta Paolo Lanzetta (= 1×) peers Winfried M. K. Amoaku

Countries citing papers authored by Paolo Lanzetta

Since Specialization
Citations

This map shows the geographic impact of Paolo Lanzetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Lanzetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Lanzetta more than expected).

Fields of papers citing papers by Paolo Lanzetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Lanzetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Lanzetta. The network helps show where Paolo Lanzetta may publish in the future.

Co-authorship network of co-authors of Paolo Lanzetta

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Lanzetta. A scholar is included among the top collaborators of Paolo Lanzetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Lanzetta. Paolo Lanzetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Jennifer I., Dilsher S. Dhoot, Avni P. Finn, et al.. (2025). Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema. Ophthalmology Retina. 9(7). 655–666. 2 indexed citations
3.
Veritti, Daniele, et al.. (2024). Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes. Ophthalmology and Therapy. 13(10). 2813–2824. 6 indexed citations
4.
Lanzetta, Paolo, Massimo Nicolò, Giovanni Staurenghi, et al.. (2023). CO71 Faricimab Versus Standard of Care in Naive Neovascular Age-Related Macular Degeneration Patients: An Indirect Treatment Comparison Using Individual Level Data. Value in Health. 26(12). S27–S27.
5.
Veritti, Daniele, et al.. (2023). Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose. Pharmaceutics. 15(5). 1416–1416. 10 indexed citations
6.
Lanzetta, Paolo, et al.. (2023). A mini-invasive surgical technique for Carlevale IOL implantation: case series study and description of concomitant surgery. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(2). 487–494. 5 indexed citations
7.
Veritti, Daniele, et al.. (2022). Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression. Journal of Clinical Medicine. 11(2). 325–325. 17 indexed citations
8.
Virgili, Gianni, Mariacristina Parravano, Davide Petri, et al.. (2022). The Association between Vision Impairment and Depression: A Systematic Review of Population-Based Studies. Journal of Clinical Medicine. 11(9). 2412–2412. 30 indexed citations
9.
Lanzetta, Paolo, et al.. (2022). Optical Coherence Tomography Findings in Rhegmatogenous Retinal Detachment: A Systematic Review. Journal of Clinical Medicine. 11(19). 5819–5819. 10 indexed citations
10.
Iglicki, Matías, Catharina Busch, Paolo Lanzetta, et al.. (2022). Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study. Eye. 37(2). 280–284. 19 indexed citations
11.
Sarao, Valentina, Mariacristina Parravano, Daniele Veritti, et al.. (2021). Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy. Institutional Research Information System (University of Udine). 9 indexed citations
12.
Korobelnik, Jean‐François, Anat Loewenstein, Bora Eldem, et al.. (2021). Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(3). 567–574. 14 indexed citations
13.
Avitabile, Teresio, Francesco Boscia, Alessandro Dell’Erba, et al.. (2020). Definition of indicators of appropriateness in the management of neovascular age-related macular degeneration: An expert opinion. European Journal of Ophthalmology. 30(4). 795–804. 3 indexed citations
14.
Veritti, Daniele, et al.. (2020). Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye. Journal of Ophthalmology. 2020. 1–9. 95 indexed citations
15.
Pignatto, Silvia, et al.. (2020). Lens-sparing vitrectomy for stage 4A retinopathy of prematurity in infants with aggressive-posterior ROP: Anatomic and functional results. European Journal of Ophthalmology. 31(4). 2020–2026. 4 indexed citations
16.
Veritti, Daniele, Valentina Sarao, & Paolo Lanzetta. (2019). A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment. Journal of Ophthalmology. 2019. 1–6. 10 indexed citations
17.
Sharma, Ashish, Baruch D. Kuppermann, Francesco Bandello, et al.. (2019). Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations—GEODEX-IOP study. Eye. 34(6). 1063–1068. 19 indexed citations
18.
Hunyor, Alex P., et al.. (2017). Topical antibiotics and intravitreal injections. Acta Ophthalmologica. 96(5). 435–441. 28 indexed citations
19.
Sarao, Valentina, Daniele Veritti, Francesco Boscia, & Paolo Lanzetta. (2014). Intravitreal Steroids for the Treatment of Retinal Diseases. The Scientific World JOURNAL. 2014. 1–14. 105 indexed citations
20.
Menchini, Francesca, et al.. (2012). Bilateral Simultaneous Nonarteritic Anterior Ischemic Optic Neuropathy after Ingestion of Sildenafil for Erectile Dysfunction. Case Reports in Medicine. 2012. 1–5. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026